InsiderTrades.com logo
The real reason Elon is fully endorsing Trump
From Porter & Company   |   Ad
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
Watch this new documentary and you’ll discover what Elon knows,

QPT Insider Trading

Insider Ownership Percentage: 17.06%
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$0.00

Quest PharmaTech Insider Trading History Chart

This chart shows the insider buying and selling history at Quest PharmaTech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Quest PharmaTech Share Price & Price History

Current Price: C$0.03
Price Change: ▼ Price Decrease of -0.01 (-28.57%)
As of 10/30/2024 10:53 AM ET

This chart shows the closing price history over time for QPT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
War on Elon Escalates…
From Porter & Company   |   Ad
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
One company holds a near-total monopoly on it.

Quest PharmaTech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/15/2023Ragupathy MadiyalakanDirectorBuy15,290C$0.07C$1,070.30
8/29/2023Ragupathy MadiyalakanDirectorBuy30,000C$0.07C$2,100.00
8/25/2023Ragupathy MadiyalakanDirectorBuy20,000C$0.07C$1,400.00
See Full Table
Election warning coming true…
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - watch it before it's too late.
Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Quest PharmaTech (CVE:QPT)

Quest PharmaTech logo
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.
Read More on Quest PharmaTech

Today's Range

Now: C$0.03
Low: C$0.03
High: C$0.03

50 Day Range

MA: C$0.03
Low: C$0.02
High: C$0.04

52 Week Range

Now: C$0.03
Low: C$0.02
High: C$0.07

Volume

207,000 shs

Average Volume

64,083 shs

Market Capitalization

C$4.23 million

P/E Ratio

N/A

Dividend Yield

6.15%

Beta

0.14

Who are the company insiders with the largest holdings of Quest PharmaTech?

Quest PharmaTech's top insider shareholders include:
  1. Ragupathy Madiyalakan (Director)
Learn More about top insider investors at Quest PharmaTech.
The real reason Elon is fully endorsing Trump
From Porter & Company   |   Ad
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
Watch this new documentary and you’ll discover what Elon knows,